Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
rickettsia infections
MeSH D012282 - rickettsia infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012288:
Rickettsiaceae infections
0 Companies
0 Drugs
Success rate
D012282:
Rickettsia infections
39 Companies
11 Drugs
$
Success rate
D014437:
Endemic flea-borne typhus
0 Companies
0 Drugs
Success rate
D014438:
Epidemic louse-borne typhus
0 Companies
0 Drugs
Success rate
D000073605:
Spotted fever group rickettsiosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
3/3
Approved:
3
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
Prednisolone
,
Prednisolone tebutate
,
Tetracycline
Pfizer
Hydrocortisone
,
Hydrocortisone butyrate
,
Hydrocortisone probutate
,
Lidocaine
,
Polymyxin b
,
Procaine
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use